BROADWAY FINANCIAL CORP DE (BYFC) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
BYFC currently has 6.18M outstanding shares. with minimal authorized share overhang for future dilution. The company has minimally diluted shareholders by 3.17% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 15, 2026 |
10-Q filing | 6.2M shares outstanding |
6.2M | 0 |
| Mar 31, 2026 |
10-K filing | 6.2M shares outstanding |
6.2M | 0 |
| Jul 24, 2025 |
10-Q filing | 6.1M shares outstanding |
6.1M | 0 |
| Mar 31, 2025 |
10-K filing | 6.0M shares outstanding |
6M | 0 |
| Nov 13, 2024 |
10-Q filing | 6.0M shares outstanding |
6M | 0 |
| Aug 14, 2024 |
10-Q filing | 6.0M shares outstanding |
6M | 0 |
| May 24, 2024 |
10-Q filing | 6.0M shares outstanding |
6M | 0 |
| May 20, 2024 |
10-Q filing | 6.0M shares outstanding |
6M | 0 |
| May 20, 2024 |
10-K filing | 6.0M shares outstanding |
6M | 0 |
| Nov 01, 2023 |
Stock Split
8-K filing: Stock split 1-for-8 | Outstanding: 49,444,456 → 9,019,187 |
9M | 0 |
| Aug 14, 2023 |
10-Q filing | 49.4M shares outstanding |
49M | 0 |
| May 16, 2023 |
10-Q filing | 48.7M shares outstanding |
49M | 0 |
| Apr 11, 2023 |
10-K filing | 48.7M shares outstanding |
49M | 0 |
| Nov 14, 2022 |
10-Q filing | 48.2M shares outstanding |
48M | 0 |
| Aug 15, 2022 |
10-Q filing | 48.0M shares outstanding |
48M | 0 |
| Jun 08, 2022 |
8-K filing: Broadway Financial Corporation closed a private placement of 150,000 shares of Series C Preferred Stock with the United States Department of the Treasury for $150,000,000. ($150.0M proceeds) |
47M | 0 |
| May 16, 2022 |
10-Q filing | 46.8M shares outstanding |
47M | 0 |
| Apr 15, 2022 |
10-K filing | 45.8M shares outstanding |
46M | 0 |
| Nov 15, 2021 |
10-Q filing | 43.7M shares outstanding |
44M | 0 |
| Aug 23, 2021 |
10-Q filing | 43.7M shares outstanding |
44M | 0 |
| May 14, 2021 |
10-Q filing | 8.8M shares outstanding |
8.8M | 0 |
| Apr 08, 2021 |
8-K filing: Broadway Financial Corporation issued 681,300 shares of Class C Common Stock in exchange for 681,300 shares of Class A Common Stock and completed sales of 18,474,000 shares of common stock for $32.88 million. ($32.88M proceeds) |
19M | 0 |
| Mar 31, 2021 |
10-K filing | 19.1M shares outstanding |
19M | 0 |
| Feb 23, 2021 |
8-K filing: Broadway Financial Corporation entered into stock purchase agreements with several investors to sell 6,293,236 shares of Class A Common Stock and 5,056,179 shares of Class C Common Stock at a price of $1.78 per share for an aggregate purchase price of $20,201,958.70. ($20.2M proceeds) |
19M | 0 |
| Nov 25, 2020 |
8-K filing: Broadway Financial Corporation entered into stock purchase agreements with Cedars-Sinai Medical Center, Banc of America Strategic Investments Corporation, and Wells Fargo Central Pacific Holdings, Inc. to sell up to 4,639,888 shares of Class A Common Stock and 1,587,162 shares of Class C Common Stock at a price of $1.78 per share for an aggregate purchase price of $11,084,149, subject to certain closing conditions including the consummation of a merger. ($11.08M proceeds) |
19M | 0 |
| Nov 16, 2020 |
10-Q filing | 19.1M shares outstanding |
19M | 0 |
| Aug 14, 2020 |
10-Q filing | 19.3M shares outstanding |
19M | 0 |
| May 15, 2020 |
10-Q filing | 19.3M shares outstanding |
19M | 0 |
| Mar 27, 2020 |
10-K filing | 19.3M shares outstanding |
19M | 0 |